Female bantamweight fighter Jessica Eye’s victory over Sarah Kaufman has been overturned to a ‘no decision’ ruling after failing a post-fight drugs test at UFC 166 in Texas.
when news of the story first broke details from the Texas commission were scarce and failed to mention the reason, leaving some to draw to the conclusion that the win had been changed due to the significant controversy over the split decision ruling in the bout last October, with many believing that former strikeforce champion, Kaufman had done enough to win.
That’s not the case though and it’s since been revealed that the ‘no decision’ came about due to the fact that Eye “tested positive for a prohibited drug.”
Eye had been all set to fight Alexis Davis at UFC 170 later this month and as things stand it appears that the fight is still on due to the fact that the year’s suspension she’s been handed down by the Texas commission has been described as “probationary.”
Essentially that means she can continue to fight as long as she adheres to the rules of her probation, though she does also have to pay a $1,875 fine.
It’s important to not that, according to the Bleacher Report, the illegal drug used by Eye was not a performance enhancer, but rather a blood thinning medication believed to have been used to treat a long-term issue stemming from an accident many years ago in which she and her father were hit by a drunk driver while walking along a road.
That incident left Eye with a broken back, among other injuries, resulting in her being bed-ridden for three months.
So, it appears this was in no way an attempt on Eye’s part to cheat in her last fight and at face value it seems like a good decision to allow her to continue to compete.
Eye is currently ranked No.6 on the UFC’s official woman’s bantamweight division, while her next opponent, Davis is No.3, so this fight could potentially have title implications at UFC 170 which just so happens to be headlined by a title fight between current champion Ronda Rousey and the No.4 ranked Sara McMann.